These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 17675523)
1. Properdin can initiate complement activation by binding specific target surfaces and providing a platform for de novo convertase assembly. Spitzer D; Mitchell LM; Atkinson JP; Hourcade DE J Immunol; 2007 Aug; 179(4):2600-8. PubMed ID: 17675523 [TBL] [Abstract][Full Text] [Related]
2. An evaluation of the role of properdin in alternative pathway activation on Neisseria meningitidis and Neisseria gonorrhoeae. Agarwal S; Ferreira VP; Cortes C; Pangburn MK; Rice PA; Ram S J Immunol; 2010 Jul; 185(1):507-16. PubMed ID: 20530262 [TBL] [Abstract][Full Text] [Related]
3. Activation of the alternative pathway of human complement by autologous cells expressing transmembrane recombinant properdin. Vuagnat BB; Mach J; Le Doussal JM Mol Immunol; 2000 Jun; 37(8):467-78. PubMed ID: 11090881 [TBL] [Abstract][Full Text] [Related]
4. Activator-specific requirement of properdin in the initiation and amplification of the alternative pathway complement. Kimura Y; Miwa T; Zhou L; Song WC Blood; 2008 Jan; 111(2):732-40. PubMed ID: 17916747 [TBL] [Abstract][Full Text] [Related]
5. The role of properdin in zymosan- and Escherichia coli-induced complement activation. Harboe M; Garred P; Lindstad JK; Pharo A; Müller F; Stahl GL; Lambris JD; Mollnes TE J Immunol; 2012 Sep; 189(5):2606-13. PubMed ID: 22851705 [TBL] [Abstract][Full Text] [Related]
6. The Role of Properdin in C5 Convertase Activity and C5b-9 Formation in the Complement Alternative Pathway. Michels MAHM; Maas RJF; van der Velden TJAM; van de Kar NCAJ; van den Heuvel LPWJ; Volokhina EB; J Immunol; 2021 Nov; 207(10):2465-2472. PubMed ID: 34635587 [TBL] [Abstract][Full Text] [Related]
7. The role of properdin in the assembly of the alternative pathway C3 convertases of complement. Hourcade DE J Biol Chem; 2006 Jan; 281(4):2128-32. PubMed ID: 16301317 [TBL] [Abstract][Full Text] [Related]
8. Properdin and complement activation: a fresh perspective. Hourcade DE Curr Drug Targets; 2008 Feb; 9(2):158-64. PubMed ID: 18288967 [TBL] [Abstract][Full Text] [Related]
9. Properdin is critical for antibody-dependent bactericidal activity against Neisseria gonorrhoeae that recruit C4b-binding protein. Gulati S; Agarwal S; Vasudhev S; Rice PA; Ram S J Immunol; 2012 Apr; 188(7):3416-25. PubMed ID: 22368277 [TBL] [Abstract][Full Text] [Related]
10. Expression and characterisation of the thrombospondin type I repeats of human properdin. Perdikoulis MV; Kishore U; Reid KB Biochim Biophys Acta; 2001 Aug; 1548(2):265-77. PubMed ID: 11513971 [TBL] [Abstract][Full Text] [Related]
11. Properdin binding to complement activating surfaces depends on initial C3b deposition. Harboe M; Johnson C; Nymo S; Ekholt K; Schjalm C; Lindstad JK; Pharo A; Hellerud BC; Nilsson Ekdahl K; Mollnes TE; Nilsson PH Proc Natl Acad Sci U S A; 2017 Jan; 114(4):E534-E539. PubMed ID: 28069958 [TBL] [Abstract][Full Text] [Related]
12. Properdin binds to late apoptotic and necrotic cells independently of C3b and regulates alternative pathway complement activation. Xu W; Berger SP; Trouw LA; de Boer HC; Schlagwein N; Mutsaers C; Daha MR; van Kooten C J Immunol; 2008 Jun; 180(11):7613-21. PubMed ID: 18490764 [TBL] [Abstract][Full Text] [Related]
13. The interaction of glycoprotein C of herpes simplex virus types 1 and 2 with the alternative complement pathway. Hung SL; Peng C; Kostavasili I; Friedman HM; Lambris JD; Eisenberg RJ; Cohen GH Virology; 1994 Sep; 203(2):299-312. PubMed ID: 8053154 [TBL] [Abstract][Full Text] [Related]
14. Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans. Agarwal S; Specht CA; Haibin H; Ostroff GR; Ram S; Rice PA; Levitz SM mBio; 2011; 2(5):. PubMed ID: 21878570 [TBL] [Abstract][Full Text] [Related]
15. Functional and structural insight into properdin control of complement alternative pathway amplification. Pedersen DV; Roumenina L; Jensen RK; Gadeberg TA; Marinozzi C; Picard C; Rybkine T; Thiel S; Sørensen UB; Stover C; Fremeaux-Bacchi V; Andersen GR EMBO J; 2017 Apr; 36(8):1084-1099. PubMed ID: 28264884 [TBL] [Abstract][Full Text] [Related]
16. Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway. Medicus RG; Götze O; Müller-Eberhard HJ J Exp Med; 1976 Oct; 144(4):1076-93. PubMed ID: 978134 [TBL] [Abstract][Full Text] [Related]
17. Properdin plays a protective role in polymicrobial septic peritonitis. Stover CM; Luckett JC; Echtenacher B; Dupont A; Figgitt SE; Brown J; Männel DN; Schwaeble WJ J Immunol; 2008 Mar; 180(5):3313-8. PubMed ID: 18292556 [TBL] [Abstract][Full Text] [Related]
18. Soluble collectin-12 mediates C3-independent docking of properdin that activates the alternative pathway of complement. Zhang J; Song L; Pedersen DV; Li A; Lambris JD; Andersen GR; Mollnes TE; Ma YJ; Garred P Elife; 2020 Sep; 9():. PubMed ID: 32909942 [TBL] [Abstract][Full Text] [Related]
19. Properdin: New roles in pattern recognition and target clearance. Kemper C; Hourcade DE Mol Immunol; 2008 Oct; 45(16):4048-56. PubMed ID: 18692243 [TBL] [Abstract][Full Text] [Related]
20. A novel mechanism of complement inhibition unmasked by a tick salivary protein that binds to properdin. Tyson KR; Elkins C; de Silva AM J Immunol; 2008 Mar; 180(6):3964-8. PubMed ID: 18322205 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]